| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.001 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.009 |